Schedule 13D ownership disclosure
MATEON THERAPEUTICS INC
Security class unavailable · CUSIP: 57667K109
Event date: 2019-04-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,545,504
- Percent of class
- 9.3900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-19-001341
- Form type
- SC 13D
- Filer
- Oncotelic Therapeutics, Inc.
- CIK
- CIK 908259
- Filed
- May 02, 2019
- Reporting period
- Apr 22, 2019
- Description
- Schedule 13D beneficial ownership